James Joseph Stec
AbbVie (United States) · 47 works · 6,046 citations · h-index 25
Top works
- Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
- Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer
- The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
- Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
- Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma
- Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
- Targeted Therapy in Breast Cancer
- Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population
- Comparison of the Predictive Accuracy of DNA Array-Based Multigene Classifiers across cDNA Arrays and Affymetrix GeneChips
- Targeted Therapies for Cancer 2004
- Effect of marathon running on inflammatory and hemostatic markers
- Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast Cancer
- Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
- Breast cancer biomarkers and molecular medicine
- Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
- Clinical Application of cDNA Microarrays in Oncology
- Breast cancer biomarkers and molecular medicine: part II
- HER-2/neu Testing in Breast Cancer
- A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding
- Cocaine-Induced Erythrocytosis and Increase in von Willebrand Factor